But it failed in treating the bleeding for the patient's postpartum primary hemorrhage [device ineffective].The patient was coagulopathic [coagulopathy].Case narrative: this spontaneous report was received from a physician via company representative referring to a female patient of unknown age.The patient's historical conditions included pregnancy (also reported as "pregnant: yes"; discrepant information) and vaginal delivery.Her concurrent conditions, concomitant medications, and allergies were not reported.This report concerns 1 patient and 1 device.Approximately on an unknown date in (b)(6) 2022 (reported as "sometime last week"), the patient was started on vacuum-induced hemorrhage control system (jada system) via vaginal route for post-partum primary hemorrhage (postpartum haemorrhage (primary)) (lot# and expiration date were not reported).The reporter stated that it sounded like everything went right with the actual device, but it failed in treating the bleeding for the patient's postpartum primary hemorrhage (device ineffective, onset date: unknown date in (b)(6) 2022).The patient was coagulopathic (coagulopathy), but it was unknown if this was discovered prior to vacuum-induced hemorrhage control system (jada system) use or after.It was also reported that for some reason the staff using it were concerned that blood went into the cannister and weren't sure if something was wrong with the device, but the healthcare professional (hcp) told them that it was normal.The patient ended up getting a hysterectomy (also reported as treatment), but other details of the patient's outcome were unknown.It was also reported that the patient sought medical attention and the patient did not die.No other adverse event (ae) and product quality complaint (pqc) were reported.No additional information was provided.The availability of vacuum-induced hemorrhage control system (jada system) was unknown.The action taken with vacuum-induced hemorrhage control system (jada system) with respect to the event of coagulopathy was reported as withdrawn approximately on an unknown date in (b)(6) 2022.The outcome of coagulopathy was unknown.The causality assessment between the event of coagulopathy and vacuum-induced hemorrhage control system (jada system) was not provided.Upon internal review, the event of "device ineffective" was determined to be serious as it required intervention.Medical device reporting criteria: serious injury.(b)(4).
|